Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Barker Appointed at Pharm-Olam | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Barker Appointed at Pharm-Olam

CRO veteran to lead corporate operations

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

John Barker has been named executive vice president, Corporate Operations at Pharm-Olam International (POI). Mr. Barker will be responsible for maintaining high-quality deliverables from POI’s range of global trial services, including government contracts, data management, biostatistics, and other functional services.

“It is a pleasure to welcome John Barker, an experienced leader, to our executive team, where his core talents will benefit our entire organization,” said John Hovre, POI’s chief operating officer. “Barker’s extensive global CRO experience will contribute greatly to serve our sponsors with excellence, and maintain Pharm-Olam’s continued global growth.”

Mr. Barker previously served in executive leadership roles, including senior vice president of Global Government Clinical Trials at PPD, vice president of Project Management at Quintiles, and executive vice president and general manager of Clinical Operations at INC Research. He had direct responsibility for quality delivery on clinical trials, as well as managing global clinical operations and corporate project management system support. Additionally, he served as a Lieutenant Colonel in the U.S. Army.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics